La segunda ponencia invitada en el XLI Congreso de la Sociedad Española de Farmacología será “Hemopatías malignas: una nueva mirada diagnóstica y terapéutica” y la impartirá Xabier Martín Martitegui el 4 de octubre a las 11:00 en la sala Lluis Dòmenec i Muntaner del CaixaForum.
A continuación incluimos una breve información sobre el ponente:
Xabier Martín Martitegui is a physician at Hematology and Hemotherapy Service in Cruces University Hospital (Bizkaia) and a researcher of the Biobizkaia Health Research Institute.
He has Master Degrees in hematopoietic transplantation and in lymphoid neoplasms. The clinical and scientific activities of Xabier Martin are focused on Oncohematology and the holistic therapeutic approach for patients with these disorders. He is author of different publication on this topic. Currently, he is the secretary of the Hematological Neoplasms Committee of the Cruces University Hospital and the secretary of ASOVASNA (Basque Navarra Association of Hematology and Hemotherapy).
He is involved in several clinical trials testing biological and pharmacological drugs in Oncohematological disorders. Currently he is the principal investigator of one clinical trial focus on use of antifungals in patients with acute leukaemia and neutropaenia. Moreover, he is the principal investigator of a research program that analyze physical exercise programs for people with cancer. He has participated in international GCP training programs to develop professional guidelines in Health Care.
La sesión estará moderada por Jabier Meana.
Sponsors
